versantis

Promethera

The company develops stem cell therapies to treat severe liver diseases for patients suffering from acute-on-chronic liver failure and other end-stage liver conditions.

Resolution Therapeutics

Resolution Therapeutics develops macrophage cell therapies to treat patients with inflammatory and fibrotic diseases such as end-stage liver disease.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

ViaNautis

ViaNautis develops polymer-based nanovesicles to deliver genetic medicines across biological barriers for patients with central nervous system and respiratory diseases.

Vivet Therapeutics SAS

This biotechnology company develops gene therapies using recombinant adeno-associated virus technologies to treat patients with rare, inherited metabolic liver diseases.

Versameb

This biopharmaceutical company develops mRNA-based therapeutics and technology platforms for protein expression to treat patients with unmet medical needs in various disease areas.

VascVersa Ltd

This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.

Satellite Bio

This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.